Freedman Financial Associates, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Freedman Financial Associates, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$42,000
+2.4%
3,3330.0%0.03%
+3.6%
Q4 2021$41,000
-24.1%
3,333
-4.8%
0.03%
-28.2%
Q3 2021$54,000
+8.0%
3,5000.0%0.04%
+2.6%
Q2 2021$50,000
-57.3%
3,500
-35.2%
0.04%
-60.8%
Q1 2021$117,000
+42.7%
5,4000.0%0.10%
+31.1%
Q4 2020$82,0005,4000.07%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders